Roivant Sciences Ltd (ROIV)
Profitability ratios
Return on sales
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | |
|---|---|---|---|---|---|
| Gross profit margin | 96.86% | 77.59% | 78.58% | 83.78% | 91.36% |
| Operating profit margin | -3,833.27% | 3,399.19% | -1,917.95% | -2,444.81% | -4,500.53% |
| Pretax margin | -2,346.02% | 3,408.33% | -1,998.74% | -1,670.85% | -3,776.20% |
| Net profit margin | -591.96% | 3,484.86% | -1,646.59% | -1,528.89% | -3,400.86% |
Roivant Sciences Ltd's gross profit margin has shown a declining trend over the years, starting at 91.36% on March 31, 2021, and decreasing to 77.59% on March 31, 2024. This may indicate challenges in maintaining efficient cost management and pricing strategies.
The operating profit margin of Roivant Sciences Ltd has been negative in the previous years, with significant improvements seen in recent years, reaching 3,399.19% on March 31, 2024. This suggests that the company has managed to control its operating expenses and generate higher profits from its core operations.
Similarly, the pretax margin was negative in the initial years but turned positive and showed significant growth, reaching 3,408.33% on March 31, 2024. This indicates that Roivant Sciences Ltd has been effective in managing its pre-tax income and expenses.
In terms of net profit margin, Roivant Sciences Ltd has also experienced negative margins in the past, but there was a substantial turnaround to a positive net profit margin of 3,484.86% on March 31, 2024. This signifies that the company was able to generate higher profits relative to its revenues after accounting for all costs and taxes.
Overall, despite facing challenges in profitability in the earlier years, Roivant Sciences Ltd has shown significant improvements in its profitability ratios in recent years, indicating better control over costs and a more efficient operation.
Return on investment
| Mar 31, 2025 | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 | Mar 31, 2021 | |
|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | -20.48% | 58.73% | -49.18% | -52.29% | -39.81% |
| Return on assets (ROA) | -3.16% | 60.21% | -42.23% | -32.70% | -30.09% |
| Return on total capital | 0.00% | 71.85% | -103.38% | -55.68% | -59.57% |
| Return on equity (ROE) | -3.67% | 72.86% | -87.15% | -51.01% | -45.01% |
Based on the provided data for Roivant Sciences Ltd, the profitability ratios exhibit significant fluctuations over the years:
1. Operating Return on Assets (Operating ROA):
- The Operating ROA has been negative for the majority of the years, indicating that the company did not generate sufficient operating income relative to its assets. In particular, the Operating ROA improved notably in the year ending March 31, 2024, reaching a positive value of 58.73%. However, there is missing data for March 31, 2025, so the trend for that year is unknown.
2. Return on Assets (ROA):
- Similar to the Operating ROA, the ROA has shown negative values for most years, signifying that the company struggled to generate net income compared to its total assets. Notably, there was a substantial increase in ROA for the year ending March 31, 2024, reaching a positive value of 60.21%. However, data for March 31, 2025, is not available for further analysis.
3. Return on Total Capital:
- The Return on Total Capital also displayed negative figures for the early years, significantly deepening in March 31, 2023, with a value of -103.38%. The ratio improved in the subsequent year, March 31, 2024, reaching a positive value of 71.85%. Notably, there is missing data for March 31, 2025, which limits a comprehensive assessment of the trend.
4. Return on Equity (ROE):
- The Return on Equity exhibited a similar pattern to the other profitability ratios, with negative values in the initial years. There was a remarkable improvement in ROE for the year ending March 31, 2024, with a positive value of 72.86%. However, the data for March 31, 2025, is not provided, hindering a complete evaluation of the company's performance in that period.
In conclusion, Roivant Sciences Ltd experienced fluctuations in profitability ratios over the years, with some improvement observed in the later periods. The lack of data for March 31, 2025, limits the ability to provide a comprehensive analysis for that year.